ArticleEpidemics2024
Scenario design for infectious disease projections: Integrating concepts from decision analysis and experimental design.
Article in Epidemics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Evaluation of respiratory disease hospitalisation forecasts using synthetic outbreak data.Communications medicine · 2026Article
- Adaptive multi-model ensembles for improved epidemic projections and decision support.medRxiv : the preprint server for health sciences · 2026Article
- Assessing human judgment forecasts in the rapid spread of the mpox outbreak: insights and challenges for pandemic preparedness.BMC infectious diseases · 2026Article
- Scenario Projections of COVID-19 Burden in the US, 2024-2025.JAMA network open · 2025Article
- Asymmetric limits on timely interventions from noisy epidemic data.Communications physics · 2025Article
- Projecting the future impact of emerging SARS-CoV-2 variants under uncertainty: Modeling the initial Omicron outbreak.Epidemics · 2024Article
- Characterising information gains and losses when collecting multiple epidemic model outputs.Epidemics · 2024Article
- The US COVID-19 and Influenza Scenario Modeling Hubs: Delivering long-term projections to guide policy.Epidemics · 2024Article
- Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty.Nature communications · 2023Article
Corrections and comments
- Commented on by
- Update of
Authors and funding
14 authors.
Funding
Abstract
Across many fields, scenario modeling has become an important tool for exploring long-term projections and how they might depend on potential interventions and critical uncertainties, with relevance to both decision makers and scientists. In the past decade, and especially during the COVID-19 pandemic, the field of epidemiology has seen substantial growth in the use of scenario projections. Multiple scenarios are often projected at the same time, allowing important comparisons that can guide the choice of intervention, the prioritization of research topics, or public communication. The design of the scenarios is central to their ability to inform important questions. In this paper, we draw on the fields of decision analysis and statistical design of experiments to propose a framework for scenario design in epidemiology, with relevance also to other fields. We identify six different fundamental purposes for scenario designs (decision making, sensitivity analysis, situational awareness, horizon scanning, forecasting, and value of information) and discuss how those purposes guide the structure of scenarios. We discuss other aspects of the content and process of scenario design, broadly for all settings and specifically for multi-model ensemble projections. As an illustrative case study, we examine the first 17 rounds of scenarios from the U.S. COVID-19 Scenario Modeling Hub, then reflect on future advancements that could improve the design of scenarios in epidemiological settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.